Detalhe da pesquisa
1.
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Br J Cancer
; 130(3): 476-482, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135713
2.
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma.
Blood
; 120(9): 1801-9, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22665938
3.
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.
Cancer Res Commun
; 3(6): 1113-1117, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377610
4.
Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.
Haematologica
; 99(9): e162-4, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24972772